Gewählte Publikation:
Hochhaus, A; Kreil, S; Corbin, A; La Rosée, P; Lahaye, T; Berger, U; Cross, NC; Linkesch, W; Druker, BJ; Hehlmann, R; Gambacorti- Passerini, C; Corneo, G; D'Incalci, M.
Roots of clinical resistance to STI-571 cancer therapy.
Science. 2001; 293(5538):2163-2163
Doi: 10.1126/science.293.5538.2163a
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Linkesch Werner
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- 0
- Find related publications in this database (using NLM MeSH Indexing)
-
Amino Acid Substitution -
-
Antineoplastic Agents - therapeutic use
-
Drug Resistance, Neoplasm -
-
Fusion Proteins, bcr-abl - chemistry Fusion Proteins, bcr-abl - genetics Fusion Proteins, bcr-abl - metabolism
-
Humans -
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
-
Piperazines - therapeutic use
-
Point Mutation -
-
Proto-Oncogene Proteins c-abl - chemistry Proto-Oncogene Proteins c-abl - genetics Proto-Oncogene Proteins c-abl - metabolism
-
Pyrimidines - therapeutic use